Condition: Complicated Intra-abdominal Infection · Sponsor: Lydia Flett
A multicentre, open label, two-arm, parallel group, pragmatic, randomised controlled trial with internal pilot. A total of 1166 consenting adult patients with cIAI will be recruited and randomised on a 1:1 basis between 28-days antibiotics and standard care antibiotics. Patients will be followed up for 180 days to determine cost effectiveness and the rate of treatment failure in each group.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Cwm Taf Morgannwg University Health Board, | Abercynon, United Kingdom | — |
| NHS Grampian | Aberdeen, United Kingdom | — |
| Hywel Dda University Health Board | Aberystwyth, United Kingdom | — |
| Buckinghamshire Healthcare NHS Trust | Aylesbury, United Kingdom | — |
| UniversityHospitals Birmingham NHS Foundation Trust | Birmingham, United Kingdom | — |
| Bolton NHS Foundation Trust | Bolton, United Kingdom | — |
| United Lincolnshire Hospitals NHS Trust - Pilgrim Hospital Boston | Boston, United Kingdom | — |
| University Hospitals Sussex NHS Foundation Trust | Brighton, United Kingdom | — |
| North Bristol NHS Trust | Bristol, United Kingdom | — |
| North Cumbria Integrated Care NHS Foundation Turst | Carlisle, United Kingdom | — |
| Chesterfield Royal Hospital NHS Foundation Trust | Chesterfield, United Kingdom | — |
| University Hospital Coventry & Warwickshire | Coventry, United Kingdom | — |
+ 24 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.